Drug shortage relief targeted as PAI Pharma acquires Nivagen to expand domestic sterile injectable production in Sacramento, Calif.
"PAI is a market leader in RTU oral liquid medicines, and that same focus on quality, reliability, and patient-centric design carries naturally into RTU injectables," said Kurt Orlofski, CEO of PAI ...
CMS uses the RAC program to detect and correct improper payments in the Medicare FFS program and provides information to CMS, ACs, and MACs that could help protect the Medicare Trust Funds by ...
Novartis has formed a strategic collaboration with drug delivery specialist Lindy Biosciences to develop self-administered versions of the Swiss pharma’s innovative drugs. For $20 million upfront, ...
The pharmaceutical injectables market is gaining more traction as vaccines and the development of biological drugs such as cell and gene therapies grow. Multiple new therapy areas have emerged and ...
"Esta expansión representa una inversión estratégica en el futuro de Piramal Pharma Ltd. Al llenar el vacío de fabricación comercial, la planta de Lexington podrá acceder al mercado de inyectables en ...
Piramal Pharma Solutions, a unit of Indian CDMO Piramal Pharma, plans to spend $80 million to expand its sterile injectables manufacturing facility in Lexington, Kentucky. The project is part of the ...
EXTON, PA — ProRx Pharma has announced the release of four injectables as part of its health and wellness product line, coupled with the expansion of its manufacturing facility to support increasing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback